| 000 | 01487 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516003657.0 | ||
| 264 | 0 | _c20110315 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1751-7176 | ||
| 024 | 7 |
_a10.1111/j.1751-7176.2010.00339.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCosta, Monica Barros | |
| 245 | 0 | 0 |
_aAldosterone antagonist decreases blood pressure and improves metabolic parameters in obese patients with the metabolic syndrome. _h[electronic resource] |
| 260 |
_bJournal of clinical hypertension (Greenwich, Conn.) _cSep 2010 |
||
| 300 |
_a753-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMineralocorticoid Receptor Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aObesity _xcomplications |
| 650 | 0 | 4 |
_aSpironolactone _xpharmacology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAndrade Ezequiel, Danielle Guedes | |
| 700 | 1 | _aMorais Lovis, Julio Cesar | |
| 700 | 1 | _aOliveira, Manoel Marques | |
| 700 | 1 | _aBaumgratz de Paula, Rogerio | |
| 773 | 0 |
_tJournal of clinical hypertension (Greenwich, Conn.) _gvol. 12 _gno. 9 _gp. 753-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1751-7176.2010.00339.x _zAvailable from publisher's website |
| 999 |
_c20211488 _d20211488 |
||